PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
-
At least 13 dead, 20 missing in Texas flash flood
-
Sabalenka outguns Raducanu to reach Wimbledon last 16
-
BRICS nations to gather without Xi, Putin
-
Heavy snow hits Turkey's northeast as wildfires rage
-
Brazil's Gabigol wins appeal in anti-doping case
-
Salah 'frightened' to return to Liverpool as fans mourn tragic Jota
-
Siraj 'loving the challenge' of leading India's attack against England
-
France says 'major issues' remain despite brandy price accord with China
-
'Always hiding': Haitian laborers fear Dominican deportation push
-
Rugby World Cup-winning Springboks coach White leaves Bulls
-
UK rock legends Oasis kick off 'historic' comeback tour
-
Alcaraz in Wimbledon last 16 as seeds tumble again
-
Kipyegon, Duplantis, Thompson highlight Eugene Diamond League
-
Australia wrest back control against West Indies
-
Erratic Alcaraz battles into Wimbledon fourth round
-
Search on for survivors of Pakistan building collapse
-
Blink and you'll miss it: Shelton wraps up match in 71 seconds
-
India on top despite Smith and Brook's hundred heroics in 2nd Test
-
Sweden beat rivals Norway at Women's Euro 2025
-
India on top despite Smith and Brook's hundred heroics in third Test
-
E.Guinea launches ICJ case against France over Paris mansion
-
Red Bull boss says Verstappen wants to stay despite Mercedes links
-
Russia brushes off talks after largest assault on Ukraine
-
Oldest surviving Tour de France yellow jersey wearer Marinelli dies at 99
-
Driven Leclerc determined to restore Ferrari to the top of F1
-
Dozens pay tribute to Liverpool star Diogo Jota in Portugal
-
Greece on high alert as heat and wind fuel fire outbreaks
-
Norris tops Silverstone practice as Horner quizzed over Verstappen
-
Brathwaite out for nought in 100th Test before West Indies rebuild
-
Russia brushes of talks after largest assault on Ukraine
-
England's James ready for Euros opener with France, says Wiegman
-
Keys latest to fall in Wimbledon wipeout as Alcaraz resumes title bid
-
Smith and Brook tons lead England revival against India in second Test
-
France praises China Cognac progress, warns of unresolved issues
-
Australian Open champion Keys stunned at Wimbledon
-
Hamas says holding consultations on Gaza truce proposal
-
Top gun Pogacar targets fourth Tour de France triumph
-
Heavy snow hits Turkey's northeast as southwest burns
-
Pakistan building collapse kills 7
-
Osaka still dreams of glory despite latest Wimbledon flop
-
Hamilton on top after opening practice for British GP
-
Alcaraz back in action at Wimbledon as Raducanu eyes Sabalenka shock
-
Court strikes suspension for Nigerian senator who complained of sexism
-
Riquelme leaves Atletico Madrid for Real Betis
-
Osaka blows chance to reach Wimbledon fourth round
-
England's Smith stuns India with blistering century in second Test
-
Meltdown: Swiss glaciers hit annual tipping point weeks early
-
Salah 'frightened' to return to Liverpool after Jota death
-
Wimbledon pays tribute to Jota after Liverpool star's death
-
Macron to co-chair Ukraine talks with Europe leaders while in UK: Elysee
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The Investor Summit Group (ISG), today announced that Ori Warshavsky, Chief Operating Officer - US Operations and Jonny Missulawin, Chief Financial Officer of PolyPid Ltd. (Nasdaq:PYPD), a late-stage biopharma company aiming to improve surgical outcomes will be presenting at this year's Investor Summit Virtual Conference on March 11th, 2025.
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid at the conference should contact their ISG representative.
About PolyPid Ltd.
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional PolyPid information, please visit http://www.polypid.com and follow on Twitter and LinkedIn.
Event: Q1 Investor Summit Virtual Conference
Presentation Time: 10:00 AM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52088
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
ACCESS Newswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESS Newswire
For More Information please visit: https://investorsummitgroup.com/
Or contact [email protected]
SOURCE: PolyPid Ltd.
View the original press release on ACCESS Newswire
P.Stevenson--AMWN
